Effects of profit-reducing policies on f
β
Darren Filson; Neal Masia
π
Article
π
2007
π
John Wiley and Sons
π
English
β 279 KB
π 1 views
## Abstract We introduce a computational model of the evolution of a valueβmaximizing researchβbased pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions, and candidate attrition rates. We use the model to estimate how the probability of surviving and covering